{
    "abstract": "Background After implementation of routine infant MenC vaccination, MenB remains a serious cause of meningococcal disease, yet to be targeted by vaccination programs in several countries. This study (NCT01339923) investigated the immunogenicity and safety of MenC CRM-conjugated vaccine (MenC-CRM) concomitantly administered with MenB vaccine (4CMenB). Methods Infants (N\u00a0=\u00a0251) were randomised 1:1 to receive 4CMenB and MenC-CRM (Group 1) or MenC-CRM alone (Group 2) at 3 and 5\u00a0months (M3, M5) and a booster at 12\u00a0months of age (M12), and pneumococcal vaccine at M3, M5, M7, M12. Antibody responses to meningococcal vaccines were measured at M3, M6, M12, and M13. Non-inferiority of MenC-CRM response in Group 1 vs Group 2 was demonstrated at M6 and M13, if the lower limit of the 95% confidence interval (LL95%CI) of the difference in percentage of infants with hSBA titres \u22651:8 was >\u221210%. Sufficiency of MenB response was achieved if LL95%CI of the percentage of infants with hSBA titres \u22651:4 against fHbp, NadA and PorA strains was \u226570% at M6 or \u226575% at M13. Adverse events (AEs) were collected for 7\u00a0days post-vaccination, and serious AEs (SAEs) and medically attended AEs throughout the study. Results Non-inferiority of MenC response in Group 1 vs Group 2 (LL95%CI \u22126.4% [M6]; \u22125.2% [M13]) and sufficiency of MenB response in Group 1 (LL95%CI 92%, 90%, 89% [M6]; 97%, 92%, 93% [M13] against fHbp, NadA, PorA, respectively) were demonstrated. Higher rates of mild to moderate solicited AEs were reported in Group 1. Unsolicited AEs and SAEs incidences were similar across groups. Conclusions Concomitant administration of MenC-CRM and 4CMenB in infants was immunogenic, resulting in non-inferior responses against MenC compared to MenC-CRM alone and demonstration of sufficient immune response to MenB, after primary and booster vaccination. Reactogenicity was higher for concomitant vaccines administration, but no safety concerns were identified.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "McIntyre"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Greenwood"
                },
                {
                    "first": "Diederik",
                    "initial": "D.",
                    "last": "Van De Beek"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61187-8",
            "firstpage": "1703",
            "issn": "01406736",
            "lastpage": "1711",
            "pmid": "23141619",
            "pub_year": 2012,
            "title": "Effect of vaccines on bacterial meningitis worldwide",
            "volume": "380"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.04.063",
            "firstpage": "B51",
            "issn": "0264410X",
            "lastpage": "B63",
            "pmid": "19477562",
            "pub_year": 2009,
            "title": "Global epidemiology of meningococcal disease",
            "volume": "27"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Ivano",
                    "initial": "I.",
                    "last": "de Filippis"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "de Lemos"
                },
                {
                    "first": "Jessica B.",
                    "initial": "J.B.",
                    "last": "Hostetler"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Wollenberg"
                },
                {
                    "first": "Claudio T.",
                    "initial": "C.T.",
                    "last": "Sacchi"
                },
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Margaret C.",
                    "initial": "M.C.",
                    "last": "Bash"
                },
                {
                    "first": "D. Rebecca",
                    "initial": "D.R.",
                    "last": "Prevots"
                }
            ],
            "doi": "10.1371/journal.pone.0033016",
            "issn": "19326203",
            "pmid": "22431994",
            "pub_year": 2012,
            "title": "Molecular epidemiology of neisseria meningitidis serogroup B in Brazil",
            "volume": "7"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Marco Aur\u00e9lio P.",
                    "initial": "M.A.P.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Luz Elena Espinosa",
                    "initial": "L.E.E.",
                    "last": "De Los Monteros"
                },
                {
                    "first": "Eduardo Luis",
                    "initial": "E.L.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e0ez-Llorens"
                },
                {
                    "first": "Ana Paula",
                    "initial": "A.P.",
                    "last": "Lemos"
                },
                {
                    "first": "Sarbelio",
                    "initial": "S.",
                    "last": "Moreno-Espinosa"
                },
                {
                    "first": "Silvia Gonz\u00e1lez",
                    "initial": "S.G.",
                    "last": "Ayala"
                },
                {
                    "first": "Juan Pablo",
                    "initial": "J.P.",
                    "last": "Torres"
                },
                {
                    "first": "Jos\u00e9 Cassio",
                    "initial": "J.C.",
                    "last": "De Moraes"
                },
                {
                    "first": "Julio Alberto",
                    "initial": "J.A.",
                    "last": "V\u00e1zquez"
                }
            ],
            "doi": "10.1586/14760584.2013.814879",
            "firstpage": "903",
            "issn": "14760584",
            "lastpage": "915",
            "pmid": "23909747",
            "pub_year": 2013,
            "title": "The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative",
            "volume": "12"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Bernadete L.",
                    "initial": "B.L.",
                    "last": "Liphaus"
                },
                {
                    "first": "Maria In\u00eas",
                    "initial": "M.I.",
                    "last": "Cappeletti-Gon\u00e7alves-Okai"
                },
                {
                    "first": "Ana Paula",
                    "initial": "A.P.",
                    "last": "Silva-Delemos"
                },
                {
                    "first": "Maria Cec\u00edlia",
                    "initial": "M.C.",
                    "last": "Gorla"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Rodriguez-Fernandes"
                },
                {
                    "first": "M\u00e1rcia Regina",
                    "initial": "M.R.",
                    "last": "Pacola"
                },
                {
                    "first": "Maria \u00c2ngela",
                    "initial": "M.A.",
                    "last": "Fernandez-Collucci"
                },
                {
                    "first": "Iara Akemi",
                    "initial": "I.A.",
                    "last": "Matsumoto-Shinkai"
                },
                {
                    "first": "F\u00e1bio",
                    "initial": "F.",
                    "last": "Takenori-Higa"
                },
                {
                    "first": "Cleide",
                    "initial": "C.",
                    "last": "Ferreira-Catani"
                },
                {
                    "first": "Eneida",
                    "initial": "E.",
                    "last": "Gon\u00e7alves-Lemes-Marques"
                },
                {
                    "first": "Telma Regina",
                    "initial": "T.R.",
                    "last": "Marques-Pinto-Carvalhanas"
                }
            ],
            "doi": "10.1016/j.eimc.2012.05.009",
            "firstpage": "88",
            "issn": "0213005X",
            "lastpage": "92",
            "pmid": "22943834",
            "pub_year": 2013,
            "title": "Outbreak of Neisseria meningitidis C in a Brazilian oil refinery involving an adjacent community",
            "volume": "31"
        },
        "b0030": {
            "authors": [
                {
                    "first": "B. P.M.",
                    "initial": "B.P.M.",
                    "last": "Iser"
                },
                {
                    "first": "H. C.A.V.",
                    "initial": "H.C.A.V.",
                    "last": "Lima"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "De Moraes"
                },
                {
                    "first": "R. P.A.",
                    "initial": "R.P.A.",
                    "last": "De Almeida"
                },
                {
                    "first": "L. T.",
                    "initial": "L.T.",
                    "last": "Watanabe"
                },
                {
                    "first": "S. L.A.",
                    "initial": "S.L.A.",
                    "last": "Alves"
                },
                {
                    "first": "A. P.S.",
                    "initial": "A.P.S.",
                    "last": "Lemos"
                },
                {
                    "first": "M. C.O.",
                    "initial": "M.C.O.",
                    "last": "Gorla"
                },
                {
                    "first": "M. G.",
                    "initial": "M.G.",
                    "last": "Gonalves"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Dos Santos"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Sobel"
                }
            ],
            "doi": "10.1017/S0950268811001610",
            "firstpage": "906",
            "issn": "09502688",
            "lastpage": "915",
            "pmid": "21875453",
            "pub_year": 2012,
            "title": "Outbreak of Neisseria meningitidis C in workers at a large food-processing plant in Brazil: Challenges of controlling disease spread to the larger community",
            "volume": "140"
        },
        "b0035": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Souza De Morais"
                },
                {
                    "first": "R. S.",
                    "initial": "R.S.",
                    "last": "Munford"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Baptista Risi"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Antezana"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Feldman"
                }
            ],
            "firstpage": "568",
            "issn": "00221899",
            "lastpage": "571",
            "pmid": "4207309",
            "pub_year": 1974,
            "title": "Epidemic disease due to serogroup C Neisseria meningitidis in Sao Paulo, Brazil",
            "volume": "129"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Ana Bel\u00e9n",
                    "initial": "A.B.",
                    "last": "Ibarz-Pav\u00f3n"
                },
                {
                    "first": "Ana Paula",
                    "initial": "A.P.",
                    "last": "Lemos"
                },
                {
                    "first": "Maria Cecilia",
                    "initial": "M.C.",
                    "last": "Gorla"
                },
                {
                    "first": "Mabel",
                    "initial": "M.",
                    "last": "Regueira"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Corso"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Gagetti"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Efron"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Sorohuet"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Moscoloni"
                },
                {
                    "first": "P. R.",
                    "initial": "P.R.",
                    "last": "Rojas"
                },
                {
                    "first": "M. C.",
                    "initial": "M.C.",
                    "last": "Brandileone"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Maldonado"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Prat"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Seoane"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Araya"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Realpe"
                },
                {
                    "first": "O. M.",
                    "initial": "O.M.",
                    "last": "Sanabria"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Duarte"
                },
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Chacon"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Llanes"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Tora\u00f1o"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Feliciano"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Guti\u00e9rrez"
                },
                {
                    "first": "C. P.",
                    "initial": "C.P.",
                    "last": "Almeida"
                },
                {
                    "first": "Y. N.",
                    "initial": "Y.N.",
                    "last": "San Mart\u00edn"
                },
                {
                    "first": "J. S.",
                    "initial": "J.S.",
                    "last": "Ch\u00f3ez"
                },
                {
                    "first": "Z. J.",
                    "initial": "Z.J.",
                    "last": "de Fuentes"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Castillo"
                },
                {
                    "first": "M. V.",
                    "initial": "M.V.",
                    "last": "Terrazas"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ech\u00e1niz-Avil\u00e9s"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Sandino"
                },
                {
                    "first": "A. O.",
                    "initial": "A.O.",
                    "last": "G\u00f3mez"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "de Quinzada"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "de Bola\u00f1os"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Fernandez"
                },
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Chamorro Cortesi"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Le\u00f3n Ayala"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Kawabata"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Morales"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Pe\u00f1a"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Nurse-Lucas"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Francis"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Camou"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "P\u00e9rez-Giffoni"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Spadola"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Payares"
                },
                {
                    "first": "C. I.",
                    "initial": "C.I.",
                    "last": "Agudelo"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Casta\u00f1eda"
                },
                {
                    "first": "Jean Marc",
                    "initial": "J.M.",
                    "last": "Gabastou"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1371/journal.pone.0044102",
            "issn": "19326203",
            "pmid": "22952888",
            "pub_year": 2012,
            "title": "Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006-2010",
            "volume": "7"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Marco Aurelio P.",
                    "initial": "M.A.P.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Eitan N.",
                    "initial": "E.N.",
                    "last": "Berezin"
                },
                {
                    "first": "Luiza Helena F.",
                    "initial": "L.H.F.",
                    "last": "Arlant"
                }
            ],
            "doi": "10.1093/jpids/piu027",
            "firstpage": "91",
            "issn": "20487193",
            "lastpage": "93",
            "pub_year": 2014,
            "title": "Meningococcal disease: Epidemiology and early effects of immunization programs",
            "volume": "3"
        },
        "b0050": {
            "authors": [
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Barroso"
                },
                {
                    "first": "Terezinha M.P.P.",
                    "initial": "T.M.P.P.",
                    "last": "Casti\u00f1eiras"
                },
                {
                    "first": "Fernanda S.",
                    "initial": "F.S.",
                    "last": "Freitas"
                },
                {
                    "first": "Jane W.",
                    "initial": "J.W.",
                    "last": "Marsh"
                },
                {
                    "first": "Mary G.",
                    "initial": "M.G.",
                    "last": "Krauland"
                },
                {
                    "first": "Mary M.",
                    "initial": "M.M.",
                    "last": "Tulenko"
                },
                {
                    "first": "\u00c9rica L.",
                    "initial": "E.L.",
                    "last": "Fonseca"
                },
                {
                    "first": "Ana C.P.",
                    "initial": "A.C.P.",
                    "last": "Vicente"
                },
                {
                    "first": "Maria C.",
                    "initial": "M.C.",
                    "last": "Rebelo"
                },
                {
                    "first": "Elaine O.",
                    "initial": "E.O.",
                    "last": "Cerqueira"
                },
                {
                    "first": "Adriano C.",
                    "initial": "A.C.",
                    "last": "Xavier"
                },
                {
                    "first": "Ana P.C.M.",
                    "initial": "A.P.C.M.",
                    "last": "Cardozo"
                },
                {
                    "first": "Simone E.M.",
                    "initial": "S.E.M.",
                    "last": "da Silva"
                },
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                }
            ],
            "doi": "10.3201/eid1911.130610",
            "firstpage": "1847",
            "issn": "10806040",
            "lastpage": "1850",
            "pmid": "24229563",
            "pub_year": 2013,
            "title": "Three outbreakcausing Neisseria meningitidis serogroup C clones, Brazil",
            "volume": "19"
        },
        "b0055": {
            "authors": [
                {
                    "first": "M\u00e1rcia de Cantu\u00e1ria",
                    "initial": "M.d.C.",
                    "last": "Tauil"
                },
                {
                    "first": "Cleidiane Santos Rodrigues",
                    "initial": "C.S.R.",
                    "last": "de Carvalho"
                },
                {
                    "first": "Ataiza C\u00e9sar",
                    "initial": "A.C.",
                    "last": "Vieira"
                },
                {
                    "first": "Eliseu Alves",
                    "initial": "E.A.",
                    "last": "Waldman"
                }
            ],
            "doi": "10.1016/j.bjid.2013.11.012",
            "firstpage": "379",
            "issn": "14138670",
            "lastpage": "386",
            "pmid": "24698710",
            "pub_year": 2014,
            "title": "Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil",
            "volume": "18"
        },
        "b0060": null,
        "b0065": {
            "authors": [
                {
                    "first": "Shruti",
                    "initial": "S.",
                    "last": "Sridhar"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Greenwood"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Head"
                },
                {
                    "first": "Stanley A.",
                    "initial": "S.A.",
                    "last": "Plotkin"
                },
                {
                    "first": "Marco A.",
                    "initial": "M.A.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Samir",
                    "initial": "S.",
                    "last": "Saha"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                },
                {
                    "first": "Oyewale",
                    "initial": "O.",
                    "last": "Tomori"
                },
                {
                    "first": "Bradford D.",
                    "initial": "B.D.",
                    "last": "Gessner"
                }
            ],
            "doi": "10.1016/S1473-3099(15)00217-0",
            "firstpage": "1334",
            "issn": "14733099",
            "lastpage": "1346",
            "pmid": "26453240",
            "pub_year": 2015,
            "title": "Global incidence of serogroup B invasive meningococcal disease: A systematic review",
            "volume": "15"
        },
        "b0070": {
            "authors": [
                {
                    "first": "C. T.",
                    "initial": "C.T.",
                    "last": "Sacchi"
                },
                {
                    "first": "L. L.",
                    "initial": "L.L.",
                    "last": "Pessoa"
                },
                {
                    "first": "S. R.",
                    "initial": "S.R.",
                    "last": "Ramos"
                },
                {
                    "first": "L. G.",
                    "initial": "L.G.",
                    "last": "Milagres"
                },
                {
                    "first": "M. C.C.",
                    "initial": "M.C.C.",
                    "last": "Camargo"
                },
                {
                    "first": "N. T.R.",
                    "initial": "N.T.R.",
                    "last": "Hidalgo"
                },
                {
                    "first": "C. E.A.",
                    "initial": "C.E.A.",
                    "last": "Melles"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Caugant"
                },
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Frasch"
                }
            ],
            "doi": "10.1128/jcm.30.7.1734-1738.1992",
            "firstpage": "1734",
            "issn": "00951137",
            "lastpage": "1738",
            "pmid": "1629328",
            "pub_year": 1992,
            "title": "Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex",
            "volume": "30"
        },
        "b0075": null,
        "b0080": {
            "authors": [
                {
                    "first": "Duccio",
                    "initial": "D.",
                    "last": "Medini"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Stella"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Wassil"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.015",
            "firstpage": "2629",
            "issn": "0264410X",
            "lastpage": "2636",
            "pmid": "25882169",
            "pub_year": 2015,
            "title": "MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine",
            "volume": "33"
        },
        "b0085": null,
        "b0090": {
            "authors": [
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Goldschneider"
                },
                {
                    "first": "E. C.",
                    "initial": "E.C.",
                    "last": "Gotschlich"
                },
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Artenstein"
                }
            ],
            "doi": "10.1084/jem.129.6.1307",
            "firstpage": "1307",
            "issn": "00221007",
            "lastpage": "1326",
            "pmid": "4977280",
            "pub_year": 1969,
            "title": "Human immunity to the meningococcus. I. The role of humoral antibodies.",
            "volume": "129"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Balmer"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.01.051",
            "firstpage": "2222",
            "issn": "0264410X",
            "lastpage": "2227",
            "pmid": "15755600",
            "pub_year": 2005,
            "title": "Meningococcal surrogates of protection - Serum bactericidal antibody activity",
            "volume": "23"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Dawson"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Holland"
                },
                {
                    "first": "Tessa M.",
                    "initial": "T.M.",
                    "last": "John"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Evans"
                },
                {
                    "first": "Karen L.",
                    "initial": "K.L.",
                    "last": "Telford"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Ypma"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Philipp",
                    "initial": "P.",
                    "last": "Oster"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1086/656741",
            "firstpage": "1127",
            "issn": "10584838",
            "lastpage": "1137",
            "pmid": "20954968",
            "pub_year": 2010,
            "title": "Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy",
            "volume": "51"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Ypma"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Kohl"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Dull"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Kimura"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61961-8",
            "firstpage": "825",
            "issn": "01406736",
            "lastpage": "835",
            "pmid": "23324563",
            "pub_year": 2013,
            "title": "Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: Results of two randomised trials",
            "volume": "381"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Gian Vincenzo",
                    "initial": "G.V.",
                    "last": "Zuccotti"
                },
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "Xie"
                },
                {
                    "first": "Michelangelo",
                    "initial": "M.",
                    "last": "Barone"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                }
            ],
            "doi": "10.4161/hv.29218",
            "firstpage": "2005",
            "issn": "21645515",
            "lastpage": "2014",
            "pmid": "25424810",
            "pub_year": 2014,
            "title": "A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II): Effects of variations of the OMV and protein content on immunogenicity and reactogenicity",
            "volume": "10"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Nicoletta",
                    "initial": "N.",
                    "last": "Gossger"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Ly Mee",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Finn"
                },
                {
                    "first": "Gianni",
                    "initial": "G.",
                    "last": "Bona"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Principi"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Etienne",
                    "initial": "E.",
                    "last": "Sokal"
                },
                {
                    "first": "Birgitta",
                    "initial": "B.",
                    "last": "Becker"
                },
                {
                    "first": "Dorothee",
                    "initial": "D.",
                    "last": "Kieninger"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Dull"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Ypma"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Kimura"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1001/jama.2012.85",
            "firstpage": "573",
            "issn": "00987484",
            "lastpage": "582",
            "pmid": "22318278",
            "pub_year": 2012,
            "title": "Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial",
            "volume": "307"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Dawson"
                },
                {
                    "first": "Philipp",
                    "initial": "P.",
                    "last": "Oster"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Evans"
                },
                {
                    "first": "Tessa M.",
                    "initial": "T.M.",
                    "last": "John"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Ohene-Kena"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Ly Mee",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Ypma"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1097/INF.0b013e3181f59f6d",
            "firstpage": "e71",
            "issn": "08913668",
            "lastpage": "e79",
            "pub_year": 2010,
            "title": "Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial",
            "volume": "29"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Gian Vincenzo",
                    "initial": "G.V.",
                    "last": "Zuccotti"
                },
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "Xie"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Kohl"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                }
            ],
            "doi": "10.4161/hv.28666",
            "firstpage": "1993",
            "issn": "21645515",
            "lastpage": "2004",
            "pmid": "25424809",
            "pub_year": 2014,
            "title": "A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I): Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB",
            "volume": "10"
        },
        "b0130": null,
        "b0135": {
            "authors": [
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Hong"
                },
                {
                    "first": "Marzia Monica",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Ala Eddine",
                    "initial": "A.E.",
                    "last": "Deghmane"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Comanducci"
                },
                {
                    "first": "Brunella",
                    "initial": "B.",
                    "last": "Brunelli"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Dull"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.12.022",
            "firstpage": "1113",
            "issn": "0264410X",
            "lastpage": "1116",
            "pmid": "23261039",
            "pub_year": 2013,
            "title": "Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?",
            "volume": "31"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Shamez N.",
                    "initial": "S.N.",
                    "last": "Ladhani"
                },
                {
                    "first": "Marzia Monica",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Alessia",
                    "initial": "A.",
                    "last": "Biolchi"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Kazim",
                    "initial": "K.",
                    "last": "Beebeejaun"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Lucidarme"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.3201/eid2202.150369",
            "firstpage": "309",
            "issn": "10806040",
            "lastpage": "311",
            "pmid": "26811872",
            "pub_year": 2016,
            "title": "Effectiveness of meningococcal B vaccine against endemic hypervirulent neisseria meningitidis W strain, England",
            "volume": "22"
        }
    },
    "body_text": [
        {
            "endOffset": 17660,
            "parents": [],
            "secId": "s0005",
            "sentence": "The main objective was to evaluate the non-inferiority of the immune response of MenC-CRM when concomitantly administered with the MenB vaccine, compared with the administration of MenC-CRM alone, after primary vaccination and following the booster dose.",
            "startOffset": 17406,
            "title": "Introduction"
        },
        {
            "endOffset": 18147,
            "parents": [],
            "secId": "s0010",
            "sentence": "This study was conducted as part of a Phase 3b open-label study investigating the immunogenicity and safety of the licensed vaccine 4CMenB administered according to reduced schedules in infants or catch-up series in children (clinicaltrials.gov: NCT01339923).",
            "startOffset": 17888,
            "title": "Methods"
        },
        {
            "endOffset": 26130,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "In Group 1, 95\u201397% of infants achieved hSBA titres \u22651:4 against the fHbp, NadA and PorA test strains after completion of the primary series (Fig. 2).",
            "startOffset": 25981,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 26454,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Sufficiency of antibody response was achieved against all three test strains after the primary and booster doses (lower limit of 95% CIs were 92%, 90%, and 89% after the primary series and 97%, 92% and 93% after the booster against fHbp, NadA and PorA, respectively).",
            "startOffset": 26187,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 25009,
            "parents": [],
            "secId": "s0040",
            "sentence": "Demographics (age and race) and baseline characteristics (height, weight, and body mass index) for infants in the two groups were very similar, although more females were enrolled in Group 1 (Supplementary Table 1).",
            "startOffset": 24794,
            "title": "Results"
        },
        {
            "endOffset": 16467,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 16466,
                    "startOffset": 16463
                }
            },
            "secId": "s0005",
            "sentence": "However, no early impact was observed in unvaccinated age groups, probably reflecting the lack of a catch-up programme targeting adolescents and young adults\u2013the age groups primarily responsible for carriage and transmission [9].",
            "startOffset": 16238,
            "title": "Introduction"
        },
        {
            "endOffset": 23381,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All analyses were performed on the per protocol set, i.e. all infants who correctly received the vaccinations, provided evaluable serum samples at one month after the primary series (M6) and had no major protocol deviations.",
            "startOffset": 23157,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34251,
            "parents": [],
            "secId": "s0070",
            "sentence": "Bexsero, Menjugate and Synflorix are trademarks of the GSK group of companies.",
            "startOffset": 34173,
            "title": "Trademark statement"
        },
        {
            "endOffset": 24087,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "For percentages of infants with hSBA titres above the thresholds, GMTs and GMRs, 95% CIs were calculated using the Clopper-Pearson method.",
            "startOffset": 23949,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31350,
            "parents": [],
            "secId": "s0055",
            "sentence": "Despite the high percentage of infants with fever following 4CMenB vaccination in the current study, only one infant had a rectal temperature \u226540 \u00b0C, which resolved within 2 days.",
            "startOffset": 31171,
            "title": "Discussion"
        },
        {
            "endOffset": 20521,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A 0.5 mL dose of the glycoconjugate MenC-CRM vaccine (Menjugate\u2122, GSK Vaccines, Italy; lot numbers: 583011, 938011) contained 10 \u03bcg of meningococcal C oligosaccharide, conjugated to CRM197.",
            "startOffset": 20332,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 33701,
            "parents": [],
            "secId": "s0060",
            "sentence": "DT designed the study.",
            "startOffset": 33679,
            "title": "Author contributions"
        },
        {
            "endOffset": 28307,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "At least one unsolicited AE was reported in 82% of infants in Group 1 and 73% in Group 2.",
            "startOffset": 28218,
            "title": "Safety"
        },
        {
            "endOffset": 24793,
            "parents": [],
            "secId": "s0040",
            "sentence": "The main reasons for not completing the study were withdrawal of consent, lost to follow-up, AE, and protocol violation (Fig. 1).",
            "startOffset": 24664,
            "title": "Results"
        },
        {
            "endOffset": 27859,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Similarly to local reactions, rates of systemic adverse reactions were highest after the first vaccination, and higher in Group 1 than Group 2 (Fig. 3).",
            "startOffset": 27707,
            "title": "Safety"
        },
        {
            "endOffset": 23948,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The power was 97% for an underlying responder rate of 98%.",
            "startOffset": 23890,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29208,
            "parents": [],
            "secId": "s0055",
            "sentence": "Reactogenicity was higher in the group that also received 4CMenB, but no concerning safety signals were identified.",
            "startOffset": 29093,
            "title": "Discussion"
        },
        {
            "endOffset": 27526,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The most commonly reported local adverse reaction following any vaccination was tenderness (Table 2).",
            "startOffset": 27425,
            "title": "Safety"
        },
        {
            "endOffset": 35318,
            "parents": [],
            "secId": "s0075",
            "sentence": "EJFL declares a grant from Novartis during the conduct of the study.",
            "startOffset": 35250,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 22969,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Medically attended AEs, solicited reactions persisting after Day 7, AEs leading to premature withdrawal from the study, and serious AEs (SAEs) were recorded throughout the study.",
            "startOffset": 22791,
            "title": "Safety"
        },
        {
            "endOffset": 31811,
            "parents": [],
            "secId": "s0055",
            "sentence": "In several countries (like Italy, United Kingdom and Ireland), 4CMenB is already recommended or used as part of the infant immunisation schedule along MenC.",
            "startOffset": 31655,
            "title": "Discussion"
        },
        {
            "endOffset": 29397,
            "parents": [],
            "secId": "s0055",
            "sentence": "A robust antibody response was seen following 4CMenB administration, which met the criteria for sufficiency against three serogroup B test strains after both the primary and booster doses.",
            "startOffset": 29209,
            "title": "Discussion"
        },
        {
            "endOffset": 35181,
            "parents": [],
            "secId": "s0075",
            "sentence": "The institution of FMT received clinical trial fees from Novartis during the conduct of this study, and he received personal fees/non-financial support/grants/other from Pfizer, SPMSD and/or GSK, outside the submitted work.",
            "startOffset": 34958,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 27101,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "At one month after the booster dose, antibody GMTs were higher than following the primary series, for all four MenB test strains (Supplementary Table 2).",
            "startOffset": 26948,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 22487,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Geometric mean titres (GMTs) and ratios (GMRs) were also calculated.",
            "startOffset": 22419,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 28650,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Across groups, 10\u201311% of infants were reported to have AEs that were judged as possibly related to the study vaccination by the investigator.",
            "startOffset": 28509,
            "title": "Safety"
        },
        {
            "endOffset": 17880,
            "parents": [],
            "secId": "s0005",
            "sentence": "Other objectives included assessment of the sufficiency of antibody response to 4CMenB after completion of the primary series and following the booster dose, and assessment of reactogenicity and safety of both vaccines.",
            "startOffset": 17661,
            "title": "Introduction"
        },
        {
            "endOffset": 20331,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A 0.5 mL dose of 4CMenB (Bexsero\u2122, GSK Vaccines, Italy; lot numbers: 101601H, 101601E, 113001AD, 101601D, 113001AA, IB139201, 101601G, 090101A5, 090101A9) contained 50 \u03bcg of each of three purified MenB antigens (factor H binding protein [fHbp], Neisseria heparin binding antigen [NHBA], and Neisserial adhesin A [NadA]), and 25 \u03bcg of outer membrane vesicles (OMV) from N. meningitidis strain NZ98/254 (PorA).",
            "startOffset": 19923,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 26774,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "GMTs for immune responses against the four MenB test strains increased at one month after primary vaccination with respect to baseline values.",
            "startOffset": 26632,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33763,
            "parents": [],
            "secId": "s0060",
            "sentence": "MAS, LYW and EDMJ conducted the study and collected the data.",
            "startOffset": 33702,
            "title": "Author contributions"
        },
        {
            "endOffset": 19535,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Infants were excluded from participation if any of the following criteria were met: previous MenB, MenC or pneumococcal vaccination; previous N. meningitidis disease; history of allergy or hypersensitivity to any of the vaccine components; an acute or chronic infection in the 7 days prior to vaccination; fever the day before vaccination, or antibiotic treatment 6 days prior to vaccination; known or suspected alteration of the immune system; severe or chronic disease; receipt of blood products in the 90 days prior to vaccination; receipt of other vaccines in the 7 days prior to vaccination; current participation in other clinical trials; or family or household member of trial staff.",
            "startOffset": 18845,
            "title": "Infants"
        },
        {
            "endOffset": 28896,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "SAEs were reported in 4% and 6% of infants in Groups 1 and 2, respectively; none of these were considered related to the study vaccination.",
            "startOffset": 28757,
            "title": "Safety"
        },
        {
            "endOffset": 31654,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although this was only a small study, as part of a larger clinical trial, the results have paramount importance for public health vaccination policies in countries such as Brazil, where a significant burden of disease is caused by these two major disease-causing serogroups in infants and young children.",
            "startOffset": 31350,
            "title": "Discussion"
        },
        {
            "endOffset": 34043,
            "parents": [],
            "secId": "s0060",
            "sentence": "All authors reviewed the manuscript and approved the final version for submission.",
            "startOffset": 33961,
            "title": "Author contributions"
        },
        {
            "endOffset": 22127,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Analysis was performed at GSK Clinical Sciences Laboratory, Marburg, Germany (MenC and NHBA test strain) and Public Health England Laboratory, Manchester, UK (fHbp, NadA and PorA test strains).",
            "startOffset": 21934,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 26631,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The percentages of infants with hSBA titres \u22651:4, against the NHBA test strain were 70% (95% CI: 58\u201379) after the primary series and 70% (95% CI: 58\u201380) after the booster dose.",
            "startOffset": 26455,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 20936,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A 0.5 mL dose of PHiD-CV vaccine (Synflorix\u2122, GSK Vaccines, Belgium; lot numbers: SPNA189CN, ASPNA410AH) contained 1 \u03bcg of each capsular polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14, and 23F, and 3 \u03bcg for serotype 4 each individually conjugated to protein D of non typeable H. influenzae, and 3 \u03bcg of capsular polysaccharide of serotypes 18C and 19F conjugated to tetanus and diphtheria toxoids, respectively.",
            "startOffset": 20522,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 25475,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Across the groups, 99\u2013100% of infants had hSBA titres \u22651:8 against MenC one month after the second vaccination (primary series), and all infants achieved these titres following the booster dose.",
            "startOffset": 25281,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 30957,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 30956,
                    "startOffset": 30952
                }
            },
            "secId": "s0055",
            "sentence": "In a study assessing the reactogenicity of 4CMenB administered to infants at 2, 3, 4, and 12 months of age together with routine paediatric vaccines, the occurrence of fever \u226538.5 \u00b0C after primary vaccination was 70.3%, compared with 27.1% in a group receiving the MenC-CRM vaccine [25].",
            "startOffset": 30670,
            "title": "Discussion"
        },
        {
            "endOffset": 24663,
            "parents": [],
            "secId": "s0040",
            "sentence": "Across the two groups, 89\u201393% of infants completed the study.",
            "startOffset": 24602,
            "title": "Results"
        },
        {
            "endOffset": 29970,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 29969,
                    "startOffset": 29962
                },
                "b0105": {
                    "endOffset": 29969,
                    "startOffset": 29962
                },
                "b0110": {
                    "endOffset": 29969,
                    "startOffset": 29962
                },
                "b0115": {
                    "endOffset": 29969,
                    "startOffset": 29962
                },
                "b0120": {
                    "endOffset": 29969,
                    "startOffset": 29962
                }
            },
            "secId": "s0055",
            "sentence": "The percentage of infants with hSBA titres \u22651:4 after 4CMenB primary series and booster was similar to previous studies in infants, where the vaccine was administered alone or concomitantly with routine infant vaccines [20\u201324].",
            "startOffset": 29743,
            "title": "Discussion"
        },
        {
            "endOffset": 17405,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this study, we investigated the immunogenicity and safety of concomitant administration of MenC CRM-conjugated vaccine (MenC-CRM) and 4CMenB.",
            "startOffset": 17261,
            "title": "Introduction"
        },
        {
            "endOffset": 24433,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Safety was evaluated descriptively.",
            "startOffset": 24398,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27962,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The most commonly reported systemic reaction after each vaccination in both groups was unusual crying.",
            "startOffset": 27860,
            "title": "Safety"
        },
        {
            "endOffset": 32086,
            "parents": [],
            "secId": "s0055",
            "sentence": "The results of this study showed that concomitant administration of 4CMenB and MenC-CRM vaccines is possible, and this could lead to lowering of the costs of vaccine administration and is likely increase compliance to vaccination schedules due to a limited number of visits.",
            "startOffset": 31812,
            "title": "Discussion"
        },
        {
            "endOffset": 22592,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Infants were observed for 30 min following each vaccination for any immediate adverse reactions.",
            "startOffset": 22496,
            "title": "Safety"
        },
        {
            "endOffset": 22790,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Local reactions were assessed separately for each vaccine in Group 1.",
            "startOffset": 22721,
            "title": "Safety"
        },
        {
            "endOffset": 35249,
            "parents": [],
            "secId": "s0075",
            "sentence": "EDM reported a grant from Novartis during the conduct of the study.",
            "startOffset": 35182,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 17260,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 17259,
                    "startOffset": 17252
                },
                "b0085": {
                    "endOffset": 17259,
                    "startOffset": 17252
                }
            },
            "secId": "s0005",
            "sentence": "Based on Meningococcal Antigen Typing System (MATS) estimates, the vaccine is predicted to cover 81% (95% confidence interval [CI]: 71\u201395) of the MenB strains causing IMD in Brazil [16,17].",
            "startOffset": 17071,
            "title": "Introduction"
        },
        {
            "endOffset": 34154,
            "parents": [],
            "secId": "s0065",
            "sentence": "This study was sponsored by Novartis Vaccines and Diagnostics, Inc., now GlaxoSmithKline Biologicals SA.",
            "startOffset": 34050,
            "title": "Funding"
        },
        {
            "endOffset": 32816,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, immunogenicity analyses were not impacted by this.",
            "startOffset": 32757,
            "title": "Discussion"
        },
        {
            "endOffset": 21933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immunogenicity against MenC was also evaluated by hSBA.",
            "startOffset": 21878,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 28508,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The most commonly reported AE by the Medical Dictionary for Regulatory Activities (MEDRA) preferred term was upper respiratory tract infection (47% and 40% of infants in Groups 1 and 2, respectively).",
            "startOffset": 28308,
            "title": "Safety"
        },
        {
            "endOffset": 30541,
            "parents": [],
            "secId": "s0055",
            "sentence": "No concerning safety signals were identified in the current study for either vaccine, although, as expected, reactogenicity was higher in the group that received concomitantly 4CMenB and MenC-CRM compared to MenC-CRM alone.",
            "startOffset": 30318,
            "title": "Discussion"
        },
        {
            "endOffset": 21526,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immunogenicity against MenB was assessed using serum bactericidal antibody assay using human complement (hSBA) against four test strains: H44/76 (fHbp), 5/99 (NadA), NZ98/254 (PorA) and M10713 (NHBA).",
            "startOffset": 21326,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 34483,
            "parents": [],
            "secId": "s0075",
            "sentence": "MAPS reported a grant from the GSK group of companies during the conduct of the study.",
            "startOffset": 34397,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 24397,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Sufficiency of immune response to 4CMenB vaccination was achieved if the lower limit of the two-sided 95% CI for the percentage of infants with hSBA titres \u22651:4 against all three of the fHbp, NadA and PorA test strains was \u226570% following the primary series or \u226575% following the booster vaccination (Group 1).",
            "startOffset": 24088,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34337,
            "parents": [],
            "secId": "s0075",
            "sentence": "MC was and, DT and IM are employees of the GSK group of companies.",
            "startOffset": 34271,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 28218,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "After the second vaccination, rectal temperature \u226540 \u00b0C was reported for one infant in Group 1, resolved within 2 days.",
            "startOffset": 28099,
            "title": "Safety"
        },
        {
            "endOffset": 27222,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Solicited reactions were reported by all infants in Group 1 and 95% of infants in Group 2 after any vaccination.",
            "startOffset": 27110,
            "title": "Safety"
        },
        {
            "endOffset": 32599,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 32598,
                    "startOffset": 32591
                },
                "b0140": {
                    "endOffset": 32598,
                    "startOffset": 32591
                }
            },
            "secId": "s0055",
            "sentence": "Furthermore, 4CMenB antigens are present and expressed in other serogroups\u2019 invasive strains, suggesting that vaccination could also provide protection against some meningococcal non-B strains [27,28].",
            "startOffset": 32398,
            "title": "Discussion"
        },
        {
            "endOffset": 34825,
            "parents": [],
            "secId": "s0075",
            "sentence": "The institution of LYW received a grant from Novartis during the conduct of this study and from the GSK group of companies outside the submitted work.",
            "startOffset": 34675,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 29092,
            "parents": [],
            "secId": "s0055",
            "sentence": "In this study, co-administration of MenC-CRM vaccine with 4CMenB was found to generate non-inferior antibody responses to MenC-CRM administered alone.",
            "startOffset": 28942,
            "title": "Discussion"
        },
        {
            "endOffset": 25920,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Antibody levels increased again following booster vaccination in both groups, but no significant difference between Group 1 and 2 was observed in terms of GMTs against MenC, as shown by overlapping 95% and GMT vaccine group ratios (Table 2).",
            "startOffset": 25679,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 22720,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Local and systemic adverse reactions, and unsolicited adverse events (AEs) were recorded for 7 days following each vaccination.",
            "startOffset": 22593,
            "title": "Safety"
        },
        {
            "endOffset": 27424,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "In both groups, local reactogenicity was higher after the first vaccination than after subsequent vaccinations, and was higher in Group 1 than in Group 2 after each vaccination (Supplementary Table 3).",
            "startOffset": 27223,
            "title": "Safety"
        },
        {
            "endOffset": 28756,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Most of these AEs were solicited AEs continuing beyond the 7-day collection window following vaccination.",
            "startOffset": 28651,
            "title": "Safety"
        },
        {
            "endOffset": 18666,
            "parents": [],
            "secId": "s0010",
            "sentence": "Written informed consent was obtained from a parent or guardian of each infant prior to enrolment in the study.",
            "startOffset": 18555,
            "title": "Methods"
        },
        {
            "endOffset": 21877,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The study was designed to comply with the European Medicines Agency recommendations for clinical evaluation of the vaccine, but at the time the protocol was established, no suitable indicator strain had been identified for NHBA, and therefore sufficiency of the immune response was only planned to be assessed against the fHbp, NadA and PorA strains.",
            "startOffset": 21527,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 25980,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "A robust immune response was seen against MenB test strains.",
            "startOffset": 25920,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 34957,
            "parents": [],
            "secId": "s0075",
            "sentence": "LYW reported personal fees as member of advisory board for the GSK group of companies, Novartis and MSD outside the submitted work.",
            "startOffset": 34826,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 27623,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Rates of reporting of tenderness were similar for both vaccines in Group 1 and lower in Group 2.",
            "startOffset": 27527,
            "title": "Safety"
        },
        {
            "endOffset": 33036,
            "parents": [],
            "secId": "s0055",
            "sentence": "In conclusion, concomitant administration of 4CMenB vaccine with MenC-CRM in infants induced robust immune responses against MenB reference strains, without clinically relevant interference with immune responses to MenC.",
            "startOffset": 32816,
            "title": "Discussion"
        },
        {
            "endOffset": 34396,
            "parents": [],
            "secId": "s0075",
            "sentence": "DT owns stock/stock options in the GSK group of companies.",
            "startOffset": 34338,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 23889,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "With a sample size of 100 evaluable infants in each group, the power for demonstrating non-inferiority was 83% after the primary vaccination series, given an underlying responder rate of 95%.",
            "startOffset": 23698,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29743,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 29742,
                    "startOffset": 29738
                }
            },
            "secId": "s0055",
            "sentence": "Although GMTs for the immune response to MenC were slightly higher when MenC-CRM was administered alone, which could potentially predict a longer persistence of individual protection, all the infants in both groups achieved protective hSBA titres \u22651:4 (the currently accepted surrogate of protection for MenC disease) after the booster dose [18].",
            "startOffset": 29397,
            "title": "Discussion"
        },
        {
            "endOffset": 21117,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "4CMenB was administered into the right thigh.",
            "startOffset": 21072,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 16626,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 16625,
                    "startOffset": 16621
                }
            },
            "secId": "s0005",
            "sentence": "In children aged <2 years, the estimated incidence of MenB disease is 2.6/100,000 population, with the serogroup causing around 39% of IMD cases in 2013 [12].",
            "startOffset": 16468,
            "title": "Introduction"
        },
        {
            "endOffset": 18437,
            "parents": [],
            "secId": "s0010",
            "sentence": "The protocol was approved by the local institutional review boards and ethics committees prior to the start of the trial.",
            "startOffset": 18316,
            "title": "Methods"
        },
        {
            "endOffset": 18315,
            "parents": [],
            "secId": "s0010",
            "sentence": "This part of the study had procedures and objectives different from the larger study and was carried out between April 2011 and December 2014, at four sites in Brazil.",
            "startOffset": 18148,
            "title": "Methods"
        },
        {
            "endOffset": 33238,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although increased reactogenicity was observed when 4CMenB was co-administered with MenC-CRM compared to MenC-CRM alone, with higher rates of fever, the safety profile of the vaccines was not affected.",
            "startOffset": 33037,
            "title": "Discussion"
        },
        {
            "endOffset": 30669,
            "parents": [],
            "secId": "s0055",
            "sentence": "Previous studies have also noted high levels of reactogenicity following receipt of 4CMenB in this age group, especially fever.",
            "startOffset": 30542,
            "title": "Discussion"
        },
        {
            "endOffset": 33911,
            "parents": [],
            "secId": "s0060",
            "sentence": "IM performed the statistical analysis.",
            "startOffset": 33873,
            "title": "Author contributions"
        },
        {
            "endOffset": 21071,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "MenC-CRM and PHiD-CV were administered intramuscularly into the left thigh, with a spacing of at least 2.5 cm between injection sites.",
            "startOffset": 20937,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 18844,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Healthy infants aged 83\u2013104 days were enrolled in the study if they were available for all scheduled visits and their parent/guardian provided written informed consent.",
            "startOffset": 18676,
            "title": "Infants"
        },
        {
            "endOffset": 27707,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Most local reactions were mild to moderate and transient in duration (see Table 3).",
            "startOffset": 27624,
            "title": "Safety"
        },
        {
            "endOffset": 15682,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 15681,
                    "startOffset": 15678
                }
            },
            "secId": "s0005",
            "sentence": "The epidemiology of invasive meningococcal disease (IMD) varies regionally and temporally, with six serogroups (A, B, C, W, X, and Y) associated with virtually all cases [2].",
            "startOffset": 15508,
            "title": "Introduction"
        },
        {
            "endOffset": 16237,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 16236,
                    "startOffset": 16230
                },
                "b0050": {
                    "endOffset": 16236,
                    "startOffset": 16230
                },
                "b0055": {
                    "endOffset": 16236,
                    "startOffset": 16230
                }
            },
            "secId": "s0005",
            "sentence": "The introduction of the MenC vaccine into the National Immunisation Programme provided an immediate reduction in incidence rates of IMD in children aged <2 years, the age group targeted for vaccination [9\u201311].",
            "startOffset": 16028,
            "title": "Introduction"
        },
        {
            "endOffset": 22418,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22417,
                    "startOffset": 22410
                },
                "b0095": {
                    "endOffset": 22417,
                    "startOffset": 22410
                }
            },
            "secId": "s0025",
            "sentence": "These thresholds represented the widely accepted surrogates for protection and the established endpoints measurements for clinical trials of meningococcal vaccines [18,19].",
            "startOffset": 22246,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 23134,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Severity of AEs (mild, moderate, severe) and relatedness to the study vaccine (not related, possibly related, probably related) were determined by the investigator.",
            "startOffset": 22970,
            "title": "Safety"
        },
        {
            "endOffset": 33960,
            "parents": [],
            "secId": "s0060",
            "sentence": "IM, MC and DT analysed and interpreted the data.",
            "startOffset": 33912,
            "title": "Author contributions"
        },
        {
            "endOffset": 19922,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All infants also received the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) at M3, M5, M7 and M12.",
            "startOffset": 19773,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 28931,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "There were no deaths in the study.",
            "startOffset": 28897,
            "title": "Safety"
        },
        {
            "endOffset": 16027,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 16026,
                    "startOffset": 16020
                },
                "b0050": {
                    "endOffset": 16026,
                    "startOffset": 16020
                }
            },
            "secId": "s0005",
            "sentence": "In 2010, motivated by the epidemiological situation and the ongoing serogroup C outbreaks, the MenC conjugate vaccine was introduced into the routine infant immunisation schedule in Brazil [9,10].",
            "startOffset": 15831,
            "title": "Introduction"
        },
        {
            "endOffset": 23697,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Non-inferiority of concomitantly administered MenC-CRM compared with its separate administration was demonstrated if the lower limit of the two-sided 95% CI of the difference between the percentage of infants with hSBA titres \u22651:8 in the co-administered group compared with the MenC-CRM group was greater than \u221210%.",
            "startOffset": 23382,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 32397,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, previous MATS analysis estimated that 4CMenB provided coverage against 81% (95% CI: 71\u201395) of the circulating MenB invasive strains in Brazil.",
            "startOffset": 32246,
            "title": "Discussion"
        },
        {
            "endOffset": 22245,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immune responses were assessed as the percentage of infants with hSBA titres \u22651:4 (MenB test strains) or \u22651:8 (MenC).",
            "startOffset": 22128,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32245,
            "parents": [],
            "secId": "s0055",
            "sentence": "In this study, immune responses were only tested against MenB reference strains, thus limiting conclusions regarding breadth of meningococcal strain coverage.",
            "startOffset": 32087,
            "title": "Discussion"
        },
        {
            "endOffset": 24499,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All statistical analyses were performed using SAS v9.1 or higher.",
            "startOffset": 24434,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31170,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 31169,
                    "startOffset": 31165
                }
            },
            "secId": "s0055",
            "sentence": "In a mass vaccination setting, lower fever rates were reported in infants than previously observed in clinical trials (10.9% after a first dose of 4CMenB), although fever was still highest in this age group [26].",
            "startOffset": 30958,
            "title": "Discussion"
        },
        {
            "endOffset": 33872,
            "parents": [],
            "secId": "s0060",
            "sentence": "EJFL participated in the collection/generation of the data and contributed materials/analysis/reagent tools.",
            "startOffset": 33764,
            "title": "Author contributions"
        },
        {
            "endOffset": 17070,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 17069,
                    "startOffset": 17065
                }
            },
            "secId": "s0005",
            "sentence": "In May 2015, a multi-component, protein-based serogroup B meningococcal vaccine, 4CMenB, was licenced in Brazil for use in persons aged 2 months up to 50 years [15].",
            "startOffset": 16905,
            "title": "Introduction"
        },
        {
            "endOffset": 19772,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Infants were randomly assigned in a 1:1 ratio using a web-based randomisation system to receive either 4CMenB and MenC-CRM (Group 1), or MenC-CRM alone (Group 2), at 3, 5 and 12 months of age (M3, M5 and M12).",
            "startOffset": 19563,
            "title": "Study design and vaccines"
        },
        {
            "endOffset": 26947,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Antibody levels then declined up to seven months after the receipt of the second vaccine dose, while remaining above baseline levels, except in the case of the NHBA strain.",
            "startOffset": 26775,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 28098,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Fever (rectal temperature \u226538 \u00b0C) was reported by 39\u201348% of infants in Group 1 after each vaccination, compared with 10\u201320% in Group 2.",
            "startOffset": 27963,
            "title": "Safety"
        },
        {
            "endOffset": 24601,
            "parents": [],
            "secId": "s0040",
            "sentence": "A total of 251 infants were enrolled in the study, 126 in Group 1 and 125 in Group 2 (Fig. 1).",
            "startOffset": 24507,
            "title": "Results"
        },
        {
            "endOffset": 25280,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Co-administration of MenC-CRM with 4CMenB was found to be non-inferior to administration of MenC-CRM alone, one month after completion of the primary series and before and one month after the booster dose (Table 1), in terms of percentages of responders.",
            "startOffset": 25026,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 26186,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "This rose to 97\u2013100% after receipt of the booster dose.",
            "startOffset": 26131,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 30318,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 30317,
                    "startOffset": 30313
                }
            },
            "secId": "s0055",
            "sentence": "For instance, in a study evaluating the immunogenicity of 4CMenB co-administered with routine vaccines according to a 3 + 1 dose schedule in infants (at 2, 4, 6 and 12 months of age), hSBA titres \u22651:4 against fHBP, NadA and PorA strains were recorded in \u226564% of infants after two doses of 4CMenB and \u226578% of infants after booster vaccination [20].",
            "startOffset": 29971,
            "title": "Discussion"
        },
        {
            "endOffset": 15830,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 15829,
                    "startOffset": 15824
                },
                "b0020": {
                    "endOffset": 15829,
                    "startOffset": 15824
                },
                "b0025": {
                    "endOffset": 15829,
                    "startOffset": 15824
                },
                "b0030": {
                    "endOffset": 15829,
                    "startOffset": 15824
                },
                "b0035": {
                    "endOffset": 15829,
                    "startOffset": 15824
                },
                "b0040": {
                    "endOffset": 15829,
                    "startOffset": 15824
                }
            },
            "secId": "s0005",
            "sentence": "Meningococcal disease is endemic in Brazil, predominantly caused by serogroups B and C, with a number of outbreaks occurring since the 1970s [3\u20138].",
            "startOffset": 15683,
            "title": "Introduction"
        },
        {
            "endOffset": 18554,
            "parents": [],
            "secId": "s0010",
            "sentence": "The study was conducted in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice.",
            "startOffset": 18438,
            "title": "Methods"
        },
        {
            "endOffset": 25678,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Following the primary series, GMTs against MenC in Group 2 (MenC-CRM) were higher than in Group 1 (4CMenB and MenC-CRM) with the 95% CI of the GMT ratio (Group 1 over Group 2) not including 1 (Table 2).",
            "startOffset": 25476,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32756,
            "parents": [],
            "secId": "s0055",
            "sentence": "A higher than expected rate of protocol deviations was observed in Group 2, and this led to a relatively small size of the post-booster per-protocol cohort.",
            "startOffset": 32600,
            "title": "Discussion"
        },
        {
            "endOffset": 21325,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Serum samples were taken at pre-vaccination (M3), one month after the second dose (M6), prior to administration of the booster dose (M12), and one month after the booster dose (M13) (Fig. 1).",
            "startOffset": 21134,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 34674,
            "parents": [],
            "secId": "s0075",
            "sentence": "MAPS received research grant from the GSK group of companies, Pfizer and Takeda and speaker\u2019s honoraria from the GSK group of companies, Pfizer and Sanofi-Pasteur outside the submitted work.",
            "startOffset": 34484,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 16905,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 16737,
                    "startOffset": 16730
                },
                "b0065": {
                    "endOffset": 16737,
                    "startOffset": 16730
                },
                "b0070": {
                    "endOffset": 16904,
                    "startOffset": 16900
                }
            },
            "secId": "s0005",
            "sentence": "Although the incidence of MenB disease in all age categories was reported to decline in the last years [11,13], it still represents a significant burden with potential for outbreaks, such as those seen in several large cities across the country in the late 1980s and 1990s [14].",
            "startOffset": 16627,
            "title": "Introduction"
        },
        {
            "endOffset": 15507,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15506,
                    "startOffset": 15503
                }
            },
            "secId": "s0005",
            "sentence": "Neisseria meningitidis is one of the most frequent causes of death in children outside the neonatal period, with the highest disease incidence in infants under 12 months of age [1].",
            "startOffset": 15326,
            "title": "Introduction"
        },
        {
            "endOffset": 33659,
            "parents": [],
            "secId": "s0055",
            "sentence": "The concomitant administration of the 4CMenB vaccine with MenC-CRM in infants might be an important strategy for the introduction of 4CMenB vaccine in countries that already have MenC vaccines in their routine immunisation schedule, by minimising the number of visits required to deliver each vaccine individually and potentially providing protection against the two predominant IMD-causing serogroups in this age group.",
            "startOffset": 33239,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X17302955",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "masafadi@uol.com.br",
                "first": "Marco Aurelio",
                "initial": "M.A.",
                "last": "Marco"
            },
            {
                "email": null,
                "first": "Federico",
                "initial": "F.",
                "last": "Martinon-Torres"
            },
            {
                "email": null,
                "first": "Lily Yin",
                "initial": "L.Y.",
                "last": "Weckx"
            },
            {
                "email": null,
                "first": "Edson Duarte",
                "initial": "E.D.",
                "last": "Moreira"
            },
            {
                "email": null,
                "first": "Eduardo Jorge",
                "initial": "E.J.",
                "last": "da Fonseca Lima"
            },
            {
                "email": null,
                "first": "Ilhem",
                "initial": "I.",
                "last": "Mensi"
            },
            {
                "email": null,
                "first": "Marco",
                "initial": "M.",
                "last": "Calabresi"
            },
            {
                "email": null,
                "first": "Daniela",
                "initial": "D.",
                "last": "Toneatto"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.03.002",
        "firstpage": "2052",
        "issn": "0264410X",
        "keywords": [
            "4CMenB",
            "Immunogenicity",
            "Infants",
            "MenC-CRM",
            "Safety"
        ],
        "lastpage": "2059",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial"
    }
}